Title: Poor Countries May Not Get Vaccine Until 2024

Content: <div id='article-page'><div id='article-content' data-media-url='//news-app-staging.s3.amazonaws.com' data-base-url='//news-app-staging.herokuapp.com' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/B.wav' data-capture-url='//staging.analytics.lingraphica.com/events/capture_news' data-article-title='Poor Countries May Not Get Vaccine Until 2024' data-article-id='5288'><script src='//news-app-staging.herokuapp.com/javascripts/getscripts.js'></script><link rel='stylesheet' href='//news-app-staging.herokuapp.com/stylesheets/article.css' type='text/css' /><div class='article'><p><span data-start-time='0' data-end-time='15604'>One organization leading the effort to get COVID-19 vaccines to poorer countries says in a report that the plan faces a &ldquo;very high&rdquo; risk of failure.</span> <span data-start-time='15604' data-end-time='24729'>Reuters news agency examined documents from the report, which has not been made public.</span> <span data-start-time='24729' data-end-time='38438'>The report was prepared for high-level officials at Gavi, an alliance of governments, drug companies, aid groups and international organizations.</span> <span data-start-time='38438' data-end-time='56042'>Gavi leads the COVAX vaccine campaign along with the World Health Organization, or WHO, and the Coalition for Epidemic Preparedness Innovations.</span> <span data-start-time='56042' data-end-time='66958'>COVAX is the main plan to vaccinate people in poor and middle-income countries against COVID-19.</span> <span data-start-time='66958' data-end-time='76250'> It aims to give out at least two billion vaccine doses by the end of 2021.</span> <span data-start-time='76250' data-end-time='89896'>That would cover 20 percent of people most at risk in 91 of the countries, which are mostly in Africa, Asia and Latin America.</span> <span data-start-time='89896' data-end-time='98771'>But Gavi&rsquo;s internal report says the COVAX program is struggling from a lack of money.</span> <span data-start-time='98771' data-end-time='110792'>The plan also faces supply risks and complex contract agreements that could make it impossible to reach its goals.</span> </p></div><div class='control-buttons-sticky' style='display:none;'><div class='control-buttons'><button title='Back' class='back' disabled='disabled'></button><button title='Play' class='play' disabled='disabled'></button><button title='Pause' class='pause' style='display:none;'></button><button title='Forward' class='forward' disabled='disabled'></button><button class='finished-reading' style='display:none;'>Done</button></div></div></div><div id='article-media'><div id='media-image'><img src='https://news-app-production.s3.amazonaws.com/articles/4763/B.jpg'/></div></div><div id='question-content' style='display:none;'><div class='vocabulary_question question-container' data-question-id=16500 data-hint-location='56042' style='display:none;'><div class='question' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/what_is_covax.wav'>What is COVAX?</div><div class='choices' data-correct-choice='the plan to vaccinate people in poor and middle-income countries against COVID-19'><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/the_name_of_a_vaccine_against_covid19.wav'><span>the name of a vaccine against COVID-19</span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/the_plan_to_vaccinate_people_in_poor_and_middleincome_countries_against_covid19.wav'><span>the plan to vaccinate people in poor and middle-income countries against COVID-19</span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/an_educational_strategy_to_teach_poor_children_to_read.wav'><span>an educational strategy to teach poor children to read</span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/a_new_medication_to_treat_those_who_are_critically_ill_with_covid19.wav'><span>a new medication to treat those who are critically ill with COVID-19</span></div></div></div><div class='multiple_choice_question question-container' data-question-id=16501 data-hint-location='76250' style='display:none;'><div class='question' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/what_region_of_the_world_was_not_listed_as_one_most_at_risk_for_limited_vaccines.wav'>What region of the world was NOT listed as one most at risk for limited vaccines?</div><div class='choices' data-correct-choice='North America'><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/latin_america.wav'><span>Latin America</span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/north_america.wav'><span>North America</span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/africa.wav'><span>Africa</span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/asia.wav'><span>Asia</span></div></div></div><div class='sentence_completion_question question-container' data-question-id=16502 data-hint-location='0' style='display:none;'><div class='question' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/the_efforts_to_get_covid19_vaccines_to_poorer_countries_face__blank_.wav'>The efforts to get COVID-19 vaccines to poorer countries face <span class='blank'>a very high risk of failure</span>.</div><div class='choices' data-correct-choice='a very high risk of failure'><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/a_high_likelihood_of_success.wav'><span>a high likelihood of success</span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/few_obstacles_.wav'><span>few obstacles </span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/limited_risks.wav'><span>limited risks</span></div><div class='choice' data-sound-name='https://news-app-production.s3.amazonaws.com/articles/4763/a_very_high_risk_of_failure.wav'><span>a very high risk of failure</span></div></div></div><div class='question-buttons'><button class='skip-button'></button><button class='hint-button'></button><button class='speak-button'></button></div></div></div>

Sound Name: https://news-app-production.s3.amazonaws.com/articles/4763/B.wav

Preview

One organization leading the effort to get COVID-19 vaccines to poorer countries says in a report that the plan faces a “very high” risk of failure. Reuters news agency examined documents from the report, which has not been made public. The report was prepared for high-level officials at Gavi, an alliance of governments, drug companies, aid groups and international organizations. Gavi leads the COVAX vaccine campaign along with the World Health Organization, or WHO, and the Coalition for Epidemic Preparedness Innovations. COVAX is the main plan to vaccinate people in poor and middle-income countries against COVID-19. It aims to give out at least two billion vaccine doses by the end of 2021. That would cover 20 percent of people most at risk in 91 of the countries, which are mostly in Africa, Asia and Latin America. But Gavi’s internal report says the COVAX program is struggling from a lack of money. The plan also faces supply risks and complex contract agreements that could make it impossible to reach its goals.

Edit | Back